1-3 of 3
Juri Sakuta, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL Point Mutation

Seiichi Okabe, MD PhD, Tetsuzo Tauchi, MDPhD, Yuko Tanaka, MDPhD, Juri Sakuta, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2769.
https://doi.org/10.1182/blood.V126.23.2769.2769
Published: 2015
Journal Articles

Dual HDAC and PI3K Inhibitor, CUDC-907 Alone or in Combination with ABL Tyrosine Kinase Inhibitor Against ABL Tyrosine Kinase Inhibitor Resistant Leukemia Cells

Seiichi Okabe, MD PhD, Tetsuzo Tauchi, MDPhD, Yuko Tanaka, MDPhD, Juri Sakuta, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3693.
https://doi.org/10.1182/blood.V126.23.3693.3693
Published: 2015
Journal Articles

BCL2L11 ( BIM ) Deletion Polymorphism Is Associated with Molecular Relapse after ABL Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia with Complete Molecular Response

Seiichiro Katagiri, MD PhD, Tetsuzo Tauchi, MD PhD, Yuu Saito, MD, Tamiko Sugro, MD, Michiyo Asano, MD, Seiichiro Yoshizawa, MD PhD, Juri Sakuta, MD PhD, Daigo Akahane, MD PhD, Yuko Tanaka, MD PhD, Nahoko Furuya, MD PhD, Keiko Ando, MD PhD, Hiroaki Fujimoto, MD, Seiichi Okabe, MD PhD, Moritaka Gotoh, MD PhD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1797.
https://doi.org/10.1182/blood.V124.21.1797.1797
Published: 2014